Pfizer, BioNTech seek emergency vaccine approval

Coronavirus

FILE – In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)

WASHINGTON (AP) — Pharmaceutical companies Pfizer and BioNTech will seek emergency government approval for their coronavirus vaccine, as the U.S. aims to begin administering doses by the end of the year.

Health and Human Services Secretary Alex Azar said the companies would seek an emergency use authorization Friday from the Food and Drug Administration. The application and clinical trial data will be reviewed by an independent board of scientists before approval is granted.

Azar says: “Hope and help are on the way.”

This week the companies said their vaccine was 95% effective.

Moderna is expected to file for emergency approval for its own vaccine candidate in the coming weeks.


© 2020 Associated Press. All Rights Reserved.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.



Don't Miss

Trending Stories